ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2025
Increasing Prostate Cancer Education and Screening for Black Men in Southeastern Michigan: Your Prostate, Your Health.
Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Benefits of Prostate Cancer Screening for Black Men.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Black Men (BM) have disproportionately higher mortality rates from prostate cancer (PCa) and present with more advanced disease. Early screening may improve outcomes. The aim of our project was to provide education, screening, and provider outreach with a long-term goal to decrease the disproportionate number of PCa deaths in BM. We conducted focus group discussions with BM to assess their perceptions and understanding of PCa and screening. Focus groups aided in the development of educational materials. Educational materials were distributed at community events. Screening was offered, at select events, using prostate-specific antigen (PSA) testing. Men with PSA levels of ≥ 4 ng/ml were contacted for follow-up. The project included training for Henry Ford Health (HFH) providers and an assessment of their PCa screening practice. We completed 4 focus groups and distributed ~ 1000 PCa educational brochures. We participated in 45 community events between March 2022 to June 30, 2023. 340 men were screened. 28 men had an elevated PSA, and 17 men did not complete follow-up. Multiple HFH provider educational sessions were conducted. Of 129 providers who completed a screening practice assessment, 78 (60%) routinely offered PSA screening to men between ages 55-69. Between 2018 to 2023 at HFH, the PSA screening rate overall increased from 8.2% to 12.7%. Although our outreach efforts were effective at increasing PSA screening, 60.7% of men screened in our community events with elevated PSA did not follow-up. Future efforts should further reduce barriers to PCa screening and follow-up.
Indexed as
Identifiers
40019704What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.